As of September 2024, Genexine has a market cap of $219.09M. This makes Genexine the world's 16906th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $264.65M | -13.74% |
2023 | $306.79M | -46.92% |
2022 | $577.94M | -68.01% |
2021 | $1.81B | -25.16% |
2018 | $2.41B | 6.71% |
2017 | $2.26B | 69.18% |
2016 | $1.34B | -8.09% |
2015 | $1.45B | 97.27% |
2014 | $737.54M | 75.00% |
2013 | $421.45M | 51.11% |
2012 | $278.90M | - |